Literature DB >> 12004191

Ageing and CNS remyelination.

Robin J M Franklin1, Chao Zhao, Fraser J Sim.   

Abstract

Remyelination of demyelinated axons in the CNS is a regenerative process that, like many others, becomes less efficient with age. This article reviews a series of studies in which toxin models of demyelination have been used to characterize this phenomenon. The delayed rate of remyelination in older animals is associated with a decrease in the rate of oligodendrocyte progenitor recruitment and in the rate at which the recruited cells differentiate into remyelinating oligodendrocytes. The differences in the behaviour of oligodendrocyte lineage cells during remyelination in young and old animals are related to the age-related changes that occur in the expression of growth factors that affect the proliferation, migration and differentiation of oligodendrocyte progenitors, and in the inflammatory process associated with toxin-induced demyelination. Based on these differences, a conceptual framework is proposed to explain the age-associated effects on remyelination, which we have called the dysregulation hypothesis, and the feasibility of reversing these effects is discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12004191     DOI: 10.1097/00001756-200205240-00001

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  22 in total

Review 1.  Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches.

Authors:  Vanja Pekovic; Christopher J Hutchison
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

2.  A novel myelin protein zero transgenic zebrafish designed for rapid readout of in vivo myelination.

Authors:  Marnie A Preston; Lisbet T Finseth; Jennifer N Bourne; Wendy B Macklin
Journal:  Glia       Date:  2019-01-09       Impact factor: 7.452

Review 3.  Inflammation in CNS neurodegenerative diseases.

Authors:  Jodie Stephenson; Erik Nutma; Paul van der Valk; Sandra Amor
Journal:  Immunology       Date:  2018-04-17       Impact factor: 7.397

Review 4.  Age-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline.

Authors:  Steven G Kohama; Douglas L Rosene; Larry S Sherman
Journal:  Age (Dordr)       Date:  2011-12-28

Review 5.  NG2-glia and their functions in the central nervous system.

Authors:  L Dimou; V Gallo
Journal:  Glia       Date:  2015-05-24       Impact factor: 7.452

6.  Neonatal Lipopolysaccharide Infection Causes Demyelination and Behavioral Deficits in Adult and Senile Rat Brain.

Authors:  Kavita Singh; Nisha Patro; M Pradeepa; Ishan Patro
Journal:  Ann Neurosci       Date:  2017-07-24

7.  Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.

Authors:  J Ronald Doucette; Rubin Jiao; Adil J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2010-01-09       Impact factor: 5.046

8.  Adult-onset deficiency in growth hormone and insulin-like growth factor-I alters oligodendrocyte turnover in the corpus callosum.

Authors:  Kun Hua; M Elizabeth Forbes; Robin J Lichtenwalner; William E Sonntag; David R Riddle
Journal:  Glia       Date:  2009-08-01       Impact factor: 7.452

9.  FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation.

Authors:  Kazem Sharifi; Yusuke Morihiro; Motoko Maekawa; Yuki Yasumoto; Hisae Hoshi; Yasuhiro Adachi; Tomoo Sawada; Nobuko Tokuda; Hisatake Kondo; Takeo Yoshikawa; Michiyasu Suzuki; Yuji Owada
Journal:  Histochem Cell Biol       Date:  2011-09-22       Impact factor: 4.304

Review 10.  Neuroplasticity and functional recovery in multiple sclerosis.

Authors:  Valentina Tomassini; Paul M Matthews; Alan J Thompson; Daniel Fuglø; Jeroen J Geurts; Heidi Johansen-Berg; Derek K Jones; Maria A Rocca; Richard G Wise; Frederik Barkhof; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2012-11-05       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.